These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25882494)

  • 1. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells.
    Di Zanni E; Fornasari D; Ravazzolo R; Ceccherini I; Bachetti T
    Exp Cell Res; 2015 Aug; 336(1):43-57. PubMed ID: 25882494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells.
    Bachetti T; Di Zanni E; Ravazzolo R; Ceccherini I
    Biochim Biophys Acta; 2015 Aug; 1849(8):1057-65. PubMed ID: 26145533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.
    Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P
    PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHOX2B Is Associated with Neuroblastoma Cell Differentiation.
    Yang L; Ke XX; Xuan F; Tan J; Hou J; Wang M; Cui H; Zhang Y
    Cancer Biother Radiopharm; 2016 Mar; 31(2):44-51. PubMed ID: 26910576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHOX2A and PHOX2B genes are highly co-expressed in human neuroblastoma.
    Longo L; Borghini S; Schena F; Parodi S; Albino D; Bachetti T; Da Prato L; Truini M; Gambini C; Tonini GP; Ceccherini I; Perri P
    Int J Oncol; 2008 Nov; 33(5):985-91. PubMed ID: 18949361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
    de Pontual L; Trochet D; Bourdeaut F; Thomas S; Etchevers H; Chompret A; Minard V; Valteau D; Brugieres L; Munnich A; Delattre O; Lyonnet S; Janoueix-Lerosey I; Amiel J
    Eur J Cancer; 2007 Nov; 43(16):2366-72. PubMed ID: 17765533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of
    Di Zanni E; Bianchi G; Ravazzolo R; Raffaghello L; Ceccherini I; Bachetti T
    Oncotarget; 2017 Sep; 8(42):72133-72146. PubMed ID: 29069774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.
    Aveic S; Pantile M; Seydel A; Esposito MR; Zanon C; Li G; Tonini GP
    Oncotarget; 2016 Feb; 7(5):5646-63. PubMed ID: 26735175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.
    Seo J; Jo SA; Hwang S; Byun CJ; Lee HJ; Cho DH; Kim D; Koh YH; Jo I
    FEBS J; 2013 Dec; 280(24):6691-701. PubMed ID: 24200051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells.
    Stockhausen MT; Sjölund J; Manetopoulos C; Axelson H
    Br J Cancer; 2005 Feb; 92(4):751-9. PubMed ID: 15685243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.
    Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC
    Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells.
    Francisco R; Pérez-Perarnau A; Cortés C; Gil J; Tauler A; Ambrosio S
    Cancer Lett; 2012 May; 318(1):42-52. PubMed ID: 22186300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The TH, ELAVL4 and GD2 gene expression as diagnostic markers of bone marrow lesions in patients with neuroblastoma].
    Druĭ AE; Tsaur GA; Popov AM; Tuponogov SN; Shorikov EV; Tsvirenko SV; Savel'ev LI; Fechina LG
    Vopr Onkol; 2012; 58(4):514-20. PubMed ID: 23607207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBX1 and MEIS1 up-regulate SOX3 gene expression by direct interaction with a consensus binding site within the basal promoter region.
    Mojsin M; Stevanovic M
    Biochem J; 2009 Dec; 425(1):107-16. PubMed ID: 19799567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phox2B mutations and the Delta-Notch pathway in neuroblastoma.
    van Limpt V; Chan A; Schramm A; Eggert A; Versteeg R
    Cancer Lett; 2005 Oct; 228(1-2):59-63. PubMed ID: 16084642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and functional consequence of PHOX2B mutations in neuroblastoma.
    Raabe EH; Laudenslager M; Winter C; Wasserman N; Cole K; LaQuaglia M; Maris DJ; Mosse YP; Maris JM
    Oncogene; 2008 Jan; 27(4):469-76. PubMed ID: 17637745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.